SB Teams With Glaxo, Implying Pressure on Biotech Deal Prices
Executive Summary
The Glaxo-SmithKline partnership to pursue bacterial genomics isn't the first research-stage alliance between large companies-indeed more of them are being signed as large companies decide to share the costs of drug research.